Viewing StudyNCT00171314



Ignite Creation Date: 2024-05-05 @ 11:54 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00171314
Status: COMPLETED
Last Update Posted: 2012-04-11
First Post: 2005-09-12

Brief Title: The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Organization Data

Organization: Novartis
Class: INDUSTRY
Study ID: CFEM345D2406
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Novartis Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators